TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmaq AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,253,113
|
1,430,938
|
1,095,886 |
| Financial expenses |
35,685
|
9,285
|
56,528 |
| Earnings before taxes |
772,931
|
915,674
|
545,837 |
| Total assets |
3,144,391
|
2,649,006
|
2,002,742 |
| Current assets |
2,893,606
|
2,373,444
|
1,703,239 |
| Current liabilities |
304,893
|
308,716
|
275,916 |
| Equity capital |
2,812,336
|
2,334,891
|
1,726,202 |
| - share capital |
10,811
|
11,382
|
12,128 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.4%
|
88.1%
|
86.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
61.7%
|
64.0%
|
49.8% |
| Return on assets (ROA) |
25.7%
|
34.9%
|
30.1% |
| Current ratio |
949.1%
|
768.8%
|
617.3% |
| Return on equity (ROE) |
27.5%
|
39.2%
|
31.6% |
| Change turnover |
-105,989
|
402,391
|
230,913 |
| Change turnover % |
-8%
|
39%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.